Trials / Conditions / Recurrent Malignant Female Reproductive System Neoplasm

Recurrent Malignant Female Reproductive System Neoplasm

6 registered clinical trials studyying Recurrent Malignant Female Reproductive System Neoplasm — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Soli NCT06126276	National Cancer Institute (NCI)	Phase 2
Recruiting	Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumo NCT05564377	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractor NCT04395079	Jonsson Comprehensive Cancer Center	Phase 2
Completed	Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With NCT03508570	M.D. Anderson Cancer Center	Phase 1
Active Not Recruiting	Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer NCT04266886	M.D. Anderson Cancer Center	N/A
Terminated	Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapse NCT03420963	M.D. Anderson Cancer Center	Phase 1